Sahl Khalid Bedri

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Forskningsbeskrivning

Based on the up to date multiple sclerosis (MS) genetics information and our expertise on the field we are working on a project to identify biomarkers for MS treatment and outcome. On another project, we are studying novel genetic variations in MS.

Artiklar

Article: ANNALS OF NEUROLOGY. 2022;91(3):417-423

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse.

McKay KA; Bedri SK; Manouchehrinia A; Stawiarz L; Olsson T; Hillert J; Fink K
Article: SCIENTIFIC REPORTS. 2021;11(1):14987

Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study.

Karrenbauer VD; Bedri SK; Hillert J; Manouchehrinia A
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:666114

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.

Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Rönnelid J; Pullerits R; Gjertsson I; Lundberg K; Månberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
Article: JOURNAL OF IMMUNOLOGY. 2019;203(4):888-898

IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.

Lindahl H; Guerreiro-Cacais AO; Bedri SK; Linnerbauer M; Lindén M; Abdelmagid N; Tandre K; Hollins C; Irving L; Glover C; Jones C; Alfredsson L; Rönnblom L; Kockum I; Khademi M; Jagodic M; Olsson T
Article: PLOS ONE. 2019;14(5):e0217208

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.

Bedri SK; Nilsson OB; Fink K; Månberg A; Hamsten C; Ayoglu B; Manouchehrinia A; Nilsson P; Olsson T; Hillert J; Grönlund H; Glaser A
Article: CLINICAL IMMUNOLOGY. 2018;187:15-25

Multiple sclerosis treatment effects on plasma cytokine receptor levels.

Bedri SK; Fink K; Manouchehrinia A; Lundström W; Kockum I; Olsson T; Hillert J; Glaser A
Article: HUMAN MOLECULAR GENETICS. 2015;24(19):5644-5654

A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.

Gu BJ; Field J; Dutertre S; Ou A; Kilpatrick TJ; Lechner-Scott J; Scott R; Lea R; Taylor BV; Stankovich J; Butzkueven H; Gresle M; Laws SM; Petrou S; Hoffjan S; Akkad DA; Graham CA; Hawkins S; Glaser A; Bedri SK; Hillert J; Matute C; Antiguedad A; ANZgene Consortium; Wiley JS
Article: BRAIN. 2015;138(Pt 3):632-643

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Goris A; Pauwels I; Gustavsen MW; van Son B; Hilven K; Bos SD; Celius EG; Berg-Hansen P; Aarseth J; Myhr K-M; D'Alfonso S; Barizzone N; Leone MA; Martinelli Boneschi F; Sorosina M; Liberatore G; Kockum I; Olsson T; Hillert J; Alfredsson L; Bedri SK; Hemmer B; Buck D; Berthele A; Knier B; Biberacher V; van Pesch V; Sindic C; Bang Oturai A; Søndergaard HB; Sellebjerg F; Jensen PEH; Comabella M; Montalban X; Pérez-Boza J; Malhotra S; Lechner-Scott J; Broadley S; Slee M; Taylor B; Kermode AG; Gourraud P-A; International Multiple Sclerosis Genetics Consorti; Sawcer SJ; Andreassen BK; Dubois B; Harbo HF
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2015;22(2):328-333

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.

Sundal C; Baker M; Karrenbauer V; Gustavsen M; Bedri S; Glaser A; Myhr K-M; Haugarvoll K; Zetterberg H; Harbo H; Kockum I; Hillert J; Wszolek Z; Rademakers R; Andersen O

Alla övriga publikationer

KI thesis / dissertation: 2019

Multiple sclerosis : from genetic variants to biomarkers

Bedri, Sahl Khalid

Anställningar

Anknuten till Forskning, Klinisk neurovetenskap, Karolinska Institutet, 2022-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2020

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI